{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T17:09:07Z","timestamp":1785863347650,"version":"3.56.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":4317,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","fertstert.org","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.fertnstert.2009.11.002","type":"journal-article","created":{"date-parts":[[2010,1,15]],"date-time":"2010-01-15T05:55:01Z","timestamp":1263534901000},"page":"1118-1121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":103,"title":["Serum antimullerian hormone (AMH) levels are elevated in adolescent girls with polycystic ovaries and the polycystic ovarian syndrome (PCOS)"],"prefix":"10.1016","volume":"94","author":[{"given":"Roger","family":"Hart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota A.","family":"Doherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Norman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Franks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan E.","family":"Dickinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Hickey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah M.","family":"Sloboda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2009.11.002_bib1","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.tem.2008.08.002","article-title":"Anti-mullerian hormone and ovarian dysfunction","volume":"19","author":"Broekmans","year":"2008","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2009.11.002_bib2","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.1210\/jc.2003-030727","article-title":"Elevated serum level of antimullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest","volume":"88","author":"Pigny","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2009.11.002_bib3","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1093\/humrep\/deh850","article-title":"Serum anti-mullerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome","volume":"20","author":"Piltonen","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2009.11.002_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"ESHRE\/ASRM Rotterdam Consensus Meeting Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2009.11.002_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2009.11.002_bib6","first-page":"505","article-title":"The ultrasound assessment of the polycystic ovary: international consensus definitions. ASRM\/ESHRE Consensus meeting on polycystic ovary syndrome","volume":"9","author":"Balen","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2009.11.002_bib7","series-title":"Polycystic ovarian syndrome","first-page":"377","article-title":"Diagnostic criteria for polycystic ovary syndrome: toward a rational approach","author":"Zawadzki","year":"1992"},{"key":"10.1016\/j.fertnstert.2009.11.002_bib8","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1093\/humrep\/del291","article-title":"Serum anti-mullerian hormone throughout the human menstrual cycle","volume":"21","author":"La Marca","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2009.11.002_bib9","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1093\/humrep\/dem101","article-title":"Stable serum levels of anti-mullerian hormone during the menstrual cycle: a prospective study in normo-ovulatory women","volume":"22","author":"Tsepelidis","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2009.11.002_bib10","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.fertnstert.2007.10.067","article-title":"Clinical uses of anti-mullerian hormone assays: pitfalls and promises","volume":"91","author":"Streuli","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2009.11.002_bib11","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.fertnstert.2007.06.023","article-title":"Serum antimullerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids","volume":"90","author":"Streuli","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2009.11.002_bib12","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ejogrb.2007.01.012","article-title":"Anti-mullerian hormone levels during hormonal contraception in women with polycystic ovary syndrome","volume":"134","author":"Somunkiran","year":"2007","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2009.11.002_bib13","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1093\/humrep\/dem258","article-title":"Serum antimullerian hormone levels and follicular cohort characteristics after pituitary suppression in the late luteal phase with oral contraceptive pills","volume":"22","author":"Arbo","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2009.11.002_bib14","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/01.AOG.0000296657.41236.10","article-title":"Vascular risk in young women with polycystic ovary and polycystic ovary syndrome","volume":"111","author":"Battaglia","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2009.11.002_bib15","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0140-6736(05)64587-4","article-title":"Effect of frequent prenatal ultrasound on birthweight: follow up at 1 year of age","volume":"348","author":"Macdonald","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2009.11.002_bib16","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1210\/jc.2006-1378","article-title":"Age at menarche: influences of prenatal and postnatal growth","volume":"92","author":"Sloboda","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2009.11.002_bib17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1055\/s-2006-939565","article-title":"Androgen physiology","volume":"24","author":"Davison","year":"2006","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2009.11.002_bib18","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.1210\/jc.2009-1342","article-title":"Prenatal determinants of uterine volume and ovarian reserve in adolescence","volume":"94","author":"Hart","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2009.11.002_bib19","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2009.11.002_bib20","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0140-6736(88)91612-1","article-title":"Polycystic ovaries\u2014a common finding in normal women","volume":"1","author":"Polson","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2009.11.002_bib21","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.fertnstert.2005.02.052","article-title":"Serum mullerian-inhibiting substance levels in adolescent girls with normal menstrual cycles or with polycystic ovary syndrome","volume":"84","author":"Siow","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2009.11.002_bib22","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/humupd\/dmp008","article-title":"Metabolic features of the reproductive phenotypes of polycystic ovary syndrome","volume":"15","author":"Moran","year":"2009","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2009.11.002_bib23","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1530\/EJE-08-0510","article-title":"Anti-mullerian hormone is associated with advanced glycosylated end products in lean women with polycystic ovary syndrome","volume":"160","author":"Diamanti-Kandarakis","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.fertnstert.2009.11.002_bib24","doi-asserted-by":"crossref","first-page":"E238","DOI":"10.1152\/ajpendo.90684.2008","article-title":"Anti-Mullerian hormone levels\u00a0reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels","volume":"296","author":"Piouka","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"Suppl 1","key":"10.1016\/j.fertnstert.2009.11.002_bib25","first-page":"138","article-title":"Adolescent menstrual health","volume":"3","author":"Adams Hillard","year":"2006","journal-title":"Pediatr Endocrinol Rev"},{"key":"10.1016\/j.fertnstert.2009.11.002_bib26","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1046\/j.1469-0705.1994.04040310.x","article-title":"Precocious signs of polycystic ovaries in obese girls","volume":"4","author":"Sampaolo","year":"1994","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2009.11.002_bib27","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.bpobgyn.2004.05.001","article-title":"Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome","volume":"18","author":"Hart","year":"2004","journal-title":"Best Pract Res Clin Obstet Gynaecol"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028209039867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028209039867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T04:49:41Z","timestamp":1729745381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028209039867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0015028209039867"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2009.11.002","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum antimullerian hormone (AMH) levels are elevated in adolescent girls with polycystic ovaries and the polycystic ovarian syndrome (PCOS)","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2009.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}